Robert, Hmmm, that ain't good. True, IBES does not display who made the upward revisions that tallied the gigantic 140% increase in earnings estimates. Some analysts permit their names to be used, some not. In Correl's case, all the big upward revisers are not listed by name.
However, I would disagree with you that upward revisions by Canadian analysts are not enough. I watched CREAF get gigantic upward revisions just before the second quarterly earnings season. But I ignored the stock because the revisions were from analysts in Singapore. And what the heck could they know, right? Well the stock was more than a double within four weeks. And I missed out.
It's hard to believe anybody would short this stock, given that it has such super low valuation measuures (price to book, price to sales). It can't go much lower than this, barring some unforseen problem, like the CEO runs off with his secretary to an island in the Carribean.
Happy Investing!
Vanni |
